Paddock Susan M, Hunter Sarah B, Leininger Thomas J
RAND Corporation, Santa Monica, CA 90407.
RAND Corporation, Santa Monica, CA 90407.
J Subst Abuse Treat. 2014 Jul;47(1):78-85. doi: 10.1016/j.jsat.2014.02.005. Epub 2014 Mar 1.
Little is known about the effect of group therapy treatment modules on symptom change during treatment and on outcomes post-treatment. Secondary analyses of depressive symptoms collected from two group therapy studies conducted in substance use treatment settings were examined (n=132 and n=44). Change in PHQ-9 scores was modeled using longitudinal growth modeling combined with random effects modeling of session effects, with time-in-treatment interacted with module theme to test moderation. In both studies, depressive symptoms significantly decreased during the active treatment phase. Symptom reductions were not significantly moderated by module theme in the larger study. However, the smaller pilot study's results suggest that future examination of module effects is warranted, given the data are compatible with differential reductions in reported symptoms being associated with attending people-themed module sessions versus thoughts-themed sessions.
关于团体治疗模块对治疗期间症状变化及治疗后结果的影响,目前所知甚少。对在物质使用治疗环境中进行的两项团体治疗研究收集的抑郁症状进行了二次分析(n = 132和n = 44)。使用纵向增长模型结合会话效应的随机效应模型对PHQ - 9分数的变化进行建模,将治疗时间与模块主题进行交互以测试调节作用。在两项研究中,抑郁症状在积极治疗阶段均显著下降。在规模较大的研究中,症状减轻并未因模块主题而得到显著调节。然而,规模较小的试点研究结果表明,鉴于数据与参加以人为主的模块课程与以思想为主的课程所报告症状的差异减少相关,未来有必要对模块效果进行研究。